Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 1, 2006, Pages 45-51

  Duffy, Stephen W ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; ONSET AGE; PRIORITY JOURNAL; SWEDEN; BREAST TUMOR; HEALTH SURVEY; LONGITUDINAL STUDY; MASS SCREENING; MIDDLE AGED; MORTALITY; POISSON DISTRIBUTION; RADIOGRAPHY; REGRESSION ANALYSIS;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; POISSON DISTRIBUTION; POPULATION SURVEILLANCE; REGRESSION ANALYSIS; SWEDEN;

EID: 33645511837     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0349     Document Type: Article

References (28)

1. Tabar L, Vitak B, Chen HH, et al. The Swedish Two-County Trial twenty years later: updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 2000;38:625-51.
2. Nyström L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 1993;341:973-8.
3. Shapiro S, Venet W, Strax P, Venet L. Periodic screening for breast cancer: the Health Insurance Plan Project and its sequelae. Baltimore: Johns Hopkins Press; 1988.
4. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer, England and Wales, 1990-8: Comparison of observed with predicted mortality. Br Med J 2000; 321:665-9.
5. Duffy SW, Tabar L, Chen HH, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties: a collaborative evaluation. Cancer 2002;95:458-69.
6. Anttila A, Koskela J, Hakama M. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen 2002;9:153-8.
7. Paci E, Duffy SW, Giorgi D, et al. Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. Br J Cancer 2002;87:65-9.
8. Törnberg S, Carstensen J, Hakulinen T, Lenner P, Hatschek T, Lundgren B. Evaluation of the effect on breast cancer mortality of population-based mammography screening programmes. J Med Screen 1994;1:184-7.
9. Jonsson H, Törnberg S, Nyström L, Lenner P. Service screening with mammography in Sweden: evaluation of effects of screening on breast cancer mortality in 40-49 years. Acta Oncol 2000;39:617-23.
10. Jonsson H, Nyström L, Törnberg S, Lenner P. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen 2001;8:152-60.
11. Jonsson H, Nyström L, Törnberg S, Lenner P. Service screening with mammography of women aged 70-74 years in Sweden. Effect on breast cancer mortality. Cancer Detect Prev 2003;27:360-9.
12. Jonsson H, Nyström L, Törnberg S, Lenner P. Service screening with mammography. Long term effects on breast cancer mortality in the county of Gävleborg, Sweden. Breast 2003;12:183-93.
13. Lenner P, Jonsson H. Excess mortality from breast cancer in relation to mammography screening in northern Sweden. J Med Screen 1997;4:6-9.
14. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003;361:1405-10.
15. Tabar L, Smith RA, Yen MF, et al. Mammographic screening: a key factor in the control of breast cancer. Cancer J 2003;9:15-27.
16. Gøtzsche PC. Mammography service screening and mortality. Lancet 2003; 326:329-30.
17. Berry DA. The utility of mammography for women aged 40-50 years (con). In: De Vita VT, Hellman S, Rosenberg SA, editors. Progress in Oncology 2002. Boston: Jones and Bartlett; 2003. p. 346-72.
18. Smith RA, Duffy SW, Tabar L, Gabe R. Screening and early detection. In: Singletary SE, Robb GL, Hortobagyi GN, editors. Advanced Therapy of Breast Disease. Hamilton (Ontario): BC Decker Inc.; 2004. p. 202-12.
19. Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organised service screening with mammography: 2. Validation with new analytic methods. Cancer Epidemiol Biomarkers Prev 2006;15:52-6.
20. Frisell J, Lidbrink E, Hellström L, Rutqvist LE. Follow-up after 11 years-update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treatment 1997;45:263-70.
21. Breslow NE, Day NE. Statistical Methods in Cancer Research. II. Design and analysis of cohort studies. Lyon: IARC Scientific Publications; 1987.
22. Duffy SW, Cuzick J, Tabar L, et al. Correcting for non-compliance bias in case-control studies to evaluate cancer screening programs. Appd Stat 2002; 51:235-43.
23. Cuzick I, Edwards R, Segnan N. Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med 1997;16:1017-29.
24. Woolf B. On estimating the relationship between blood group and disease. Ann Hum Genet 1995;19:251-3.
25. Baker SG, Kramer BS, Prorok PC. Statistical issues in randomized trials of cancer screening. BMC Med Res Methodol 2002;2:11.
26. Tabar L, Vitak B, Yen MFA, Chen HHT, Smith RA, Duffy SW. Number needed to screen: lives saved over 20 years of follow-up in mammographic screening. J Med Screen 2004;11:126-9.
27. Black WC, Haggstrom DA, Welch HG. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 1995;87:720-31.
28. Thornton H, Edwards A, Baum M. Women need better information about routine mammography. Br Med J 2003;327:101-3.